What Is Tirzepatide?
The dual GLP-1 / GIP agonist explained — mechanism and lab handling.
Home › Compound guides › Semaglutide
The original of the GLP-1 family and the most studied of the three. Here's what semaglutide is, how it works, and how it's handled in the lab.
If you've heard of any peptide in this family, it's probably semaglutide. It's the longest-studied of the GLP-1 receptor agonists and the reference point everything newer — tirzepatide, retatrutide — gets compared against.
Semaglutide is a synthetic peptide that acts as a GLP-1 receptor agonist — it targets a single receptor, GLP-1, which is central to the body's glucose and appetite signalling. It's supplied to researchers as a lyophilized powder and is the most extensively studied compound in the family.
An agonist switches a receptor on. Semaglutide engages the GLP-1 receptor, part of the incretin system — the same signalling pathway that newer dual and triple agonists build on. Because it focuses on one well-characterised target, semaglutide is often the starting point for understanding how this whole class of peptides behaves.
Semaglutide is the single-receptor original; tirzepatide added a second, retatrutide a third.
| Compound | Type | Receptors |
|---|---|---|
| Semaglutide | Single agonist | GLP-1 |
| Tirzepatide | Dual agonist | GLP-1 + GIP |
| Retatrutide | Triple agonist | GLP-1 + GIP + glucagon |
Being the "simplest" doesn't make semaglutide lesser — it's the most validated and the backbone of the family's research.
Confirm what's in the vial before anything else. A reputable source provides a Certificate of Analysis (COA) with third-party HPLC purity and mass-spec identity for that batch — here's how to read one.
We recommend Vital Chems for tested compounds and bacteriostatic water.